By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Newron Pharmaceuticals 

Via R. Lepetit
21040
Gerenzano      Italy
Phone: 39-02-9668131 Fax: 39-02-96681333


SEARCH JOBS


Industry
Pharmaceutical






Company News
Newron Pharmaceuticals (NWRN) Completes CHF24.3M/US$25.5 Million In Private Placement From Leading EU And US Investors 4/30/2015 1:26:37 PM
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/25/2015 12:57:59 PM
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/24/2015 11:25:49 AM
Newron Pharmaceuticals (NWRN) To Present At The 27th Annual ROTH Conference 3/4/2015 11:28:04 AM
Newron Pharmaceuticals (NWRN) Reports 2014 Financial Results 3/4/2015 11:25:18 AM
Newron Pharmaceuticals (NWRN) Release: Xadago (Safinamide) New Drug Application (NDA) Accepted For Filing By The FDA 3/2/2015 11:18:52 AM
Newron Pharmaceuticals (NWRN) To Present At The 17th Annual BIO CEO & Investor Conference And The Leerink Global Healthcare Conference 2/6/2015 12:00:35 PM
Newron Pharmaceuticals (NWRN) Initiates Phase 2 Study Of sNN0029 In Patients With Amyotrophic Lateral Sclerosis 1/16/2015 3:03:53 PM
Newron Pharmaceuticals (NWRN) Announces Results Of Phase I Study Of NW-3509 Phase II Study In Schizophrenia Patients Planned For Q2 2015 1/15/2015 8:55:25 AM
Newron Pharmaceuticals (NWRN) Initiates Phase 2 Study Of sNN0031 In Patients With Parkinson’s disease 1/14/2015 9:18:52 AM
123456789
//-->